BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/24/2022 2:13:21 PM | Browse: 994 | Download: 2862
Publication Name World Journal of Hepatology
Manuscript ID 66640
Country Ukraine
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Randomized Clinical Trial
Article Title Effect of a specific Escherichia coli Nissle 1917 strain on minimal/mild hepatic encephalopathy treatment
Manuscript Source Invited Manuscript
All Author List Elina Manzhalii, Valentyna Moyseyenko, Vitalii Kondratiuk, Nataliia Molochek, Tetyana Falalyeyeva and Nazarii Kobyliak
ORCID
Author(s) ORCID Number
Elina Manzhalii http://orcid.org/0000-0003-0920-4627
Valentyna Moyseyenko http://orcid.org/0000-0003-1402-6028
Vitalii Kondratiuk http://orcid.org/0000-0002-4891-2338
Nataliia Molochek http://orcid.org/0000-0001-6790-5099
Tetyana Falalyeyeva http://orcid.org/0000-0002-4415-9676
Nazarii Kobyliak http://orcid.org/0000-0001-9814-689X
Funding Agency and Grant Number
Corresponding Author Nazarii Kobyliak, PhD, Associate Professor, Department of Endocrinology, Bogomolets National Medical University, Pushkinska 22a str, Kyiv 01601, Ukraine. nazariikobyliak@gmail.com
Key Words Hepatic encephalopathy; Chronic liver disease; cirrhosis; Gut microbiota; E. coli Nissle 1917; Cognitive functions; Stroop test; Rifaximin; Lactulose
Core Tip In a prospective, single-centre, open-label, randomized study, the short-term efficacy and safety of Escherichia coli Nissle (EcN) 1917 compared to that of lactulose and rifaximin in patients with hepatic encephalopathy were evaluated. The probiotic reduced the ammonia content and the level of serum proinflammatory cytokines, normalized the gut microbiota composition and improved the cognitive functions of patients with hepatic encephalopathy. The application of the EcN strain was more effective than lactulose treatment.
Publish Date 2022-03-24 14:13
Citation Manzhalii E, Moyseyenko V, Kondratiuk V, Molochek N, Falalyeyeva T, Kobyliak N. Effect of a specific Escherichia coli Nissle 1917 strain on minimal/mild hepatic encephalopathy treatment. World J Hepatol 2022; 14(3): 634-646
URL https://www.wjgnet.com/1948-5182/full/v14/i3/634.htm
DOI https://dx.doi.org/10.4254/wjh.v14.i3.634
Full Article (PDF) WJH-14-634.pdf
Full Article (Word) WJH-14-634.docx